Patent Settlements in the Pharmaceutical Industry: Balancing Intellectual Property and Antitrust Concerns

Bret Dickey and Kelly Lear Nordby write about patent settlement agreements in the US pharmaceutical industry and the complexity of balancing the benefits of innovation and the potentially anticompetitive effects of these settlement agreements.

Read the article.